MC1357A1 - 2,3-INDOLEDIONE DERIVATIVES - Google Patents

2,3-INDOLEDIONE DERIVATIVES

Info

Publication number
MC1357A1
MC1357A1 MC801482A MC1482A MC1357A1 MC 1357 A1 MC1357 A1 MC 1357A1 MC 801482 A MC801482 A MC 801482A MC 1482 A MC1482 A MC 1482A MC 1357 A1 MC1357 A1 MC 1357A1
Authority
MC
Monaco
Prior art keywords
indoledione
derivatives
indoledione derivatives
Prior art date
Application number
MC801482A
Other languages
French (fr)
Inventor
J Osbond
G Fothergill
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1357A1 publication Critical patent/MC1357A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MC801482A 1979-12-07 1980-11-26 2,3-INDOLEDIONE DERIVATIVES MC1357A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7942324 1979-12-07

Publications (1)

Publication Number Publication Date
MC1357A1 true MC1357A1 (en) 1981-08-10

Family

ID=10509706

Family Applications (1)

Application Number Title Priority Date Filing Date
MC801482A MC1357A1 (en) 1979-12-07 1980-11-26 2,3-INDOLEDIONE DERIVATIVES

Country Status (16)

Country Link
US (1) US4395559A (en)
EP (1) EP0030380A1 (en)
JP (1) JPS5695167A (en)
AR (1) AR226869A1 (en)
AU (1) AU6494680A (en)
DK (1) DK522180A (en)
ES (1) ES497530A0 (en)
FI (1) FI803727L (en)
GR (1) GR72136B (en)
HU (1) HU180620B (en)
IL (1) IL61603A0 (en)
MC (1) MC1357A1 (en)
NO (1) NO803693L (en)
NZ (1) NZ195702A (en)
PT (1) PT72176B (en)
ZA (1) ZA807494B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593106A (en) * 1984-06-04 1986-06-03 Smithkline Beckman Corporation 4-[2-(dialkylamino)ethyl]-7-hydroxyisatins
US4847863A (en) * 1985-10-03 1989-07-11 Watson Bruce W Expandable modular data modem
AR016384A1 (en) * 1997-07-30 2001-07-04 Smithkline Beecham Corp INHIBITORS OF CASPASAS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH INHIBITORS OF CASPASAS AND USE OF CASPASE INHIBITORS TO PREPARE A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF APOPTOSIS AND DISORDERS ASSOCIATED WITH EXCESSIVE ACTIVITY ILL-1 CONVERT.
ES2347027T3 (en) 1998-05-22 2010-10-22 The Board Of Trustees Of The Leland Stanford Junior University BIFUNCTIONAL MOLECULES AND THERAPIES BASED ON THE SAME.
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
PT3395372T (en) 2009-02-20 2022-05-05 Enhanx Biopharm Inc Glutathione-based drug delivery system
KR101741629B1 (en) 2009-05-06 2017-05-31 라보라토리 스킨 케어, 인크. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1778174A (en) * 1926-05-30 1930-10-14 Gen Aniline Works Inc Substituted isatins and process of preparing them
GB1069343A (en) * 1963-09-10 1967-05-17 Ici Ltd Propanolamine derivatives
CH472404A (en) * 1966-03-04 1969-05-15 Sandoz Ag Process for the production of new indole derivatives
SE379196B (en) * 1971-06-24 1975-09-29 Sandoz Ag
US4137331A (en) * 1974-06-19 1979-01-30 Sandoz Ltd. 3-Piperidino-2-hydroxypropoxy substituted-2-indolinones
US4212804A (en) * 1978-12-04 1980-07-15 Sandoz, Inc. Process for the preparation of optionally substituted 2,3-indolinediones

Also Published As

Publication number Publication date
HU180620B (en) 1983-03-28
GR72136B (en) 1983-09-20
ZA807494B (en) 1981-11-25
PT72176B (en) 1982-07-05
PT72176A (en) 1981-01-01
FI803727A7 (en) 1981-06-08
JPS5695167A (en) 1981-08-01
AR226869A1 (en) 1982-08-31
NZ195702A (en) 1984-09-28
IL61603A0 (en) 1981-01-30
EP0030380A1 (en) 1981-06-17
ES8205770A1 (en) 1982-07-01
DK522180A (en) 1981-06-08
NO803693L (en) 1981-06-09
AU6494680A (en) 1981-06-11
FI803727L (en) 1981-06-08
US4395559A (en) 1983-07-26
ES497530A0 (en) 1982-07-01

Similar Documents

Publication Publication Date Title
LU80925A1 (en) DEHYDROCYCLICIMINO-ACIDS DERIVATIVES
DK343980A (en) 2,4,6-triiodo-isophthalic acid derivatives
DK343880A (en) 2,4,6-triiodo-isophthalic acid derivatives
DK537780A (en) 1,8-naphthyridin-DERIVATIVES
DK3881A (en) SUBSTITUTED 9,10-ANTHRACEN BISHYDRAZONS
FI792769A7 (en) 3,4,5-TRIHYDROXYPIPERIDINE DERIVATIVES
SE8008339L (en) 24,24-DIFLUORO-1ALFA, 25-DIHYDROXIKOLEKALCIFEROL
FI872955A7 (en) 1-cyclohexenylmethylethyl-pyrrolidine derivatives.
MC1357A1 (en) 2,3-INDOLEDIONE DERIVATIVES
IT1151077B (en) 24,24-difluoro-25-hydroxycholecalciferol
MC1184A1 (en) OXADIAZOLOPYRIMIDINE DERIVATIVES
MX9202739A (en) ACILATED LAIDLOMICINE DERIVATIVES.
FI812196A7 (en) New halophenyl-pyridylallylamine derivatives.
ES495819A0 (en) PROCEDURE FOR PREPARING DERIVATIVES 1,2,4-OXADIAZOLIN-5-ONI-COS
DK267781A (en) 2,3-BIS-HYDROXYBENZYL DERIVATIVES
MC1183A1 (en) OXADIAZOLOPYRIMIDINE DERIVATIVES
MC1347A1 (en) PYRIDAZOPYRIDAZINE DERIVATIVES
FI803855A7 (en) Carboximidediamide derivatives.
BE885204A (en) CHOLECALCIFEROL DERIVATIVES
FI801473A7 (en) FRAMSTAELLNINGSFOERFARANDE FOER 5-MERKAPTO-1,2,3-TRIAZOLER
DK573678A (en) 3,4-methano-pyrrolidine derivatives
FI800736A7 (en) 1,1'-diphenyl-2-ylalkylamine derivatives.
BE883295A (en) 6,7-SECOERGOLINES
DK319978A (en) HERBICID EFFICIENT 1,2,4-TRIAZIN-5-AN DERIVATIVES
NL7812127A (en) N'-PHENYL-N-METHYLUREA DERIVATIVES.

Legal Events

Date Code Title Description
YP Annual fee paid